OSTFX
Price
$20.10
Change
-$0.00 (-0.00%)
Updated
Dec 26 closing price
Net Assets
150M
VFFSX
Price
$339.11
Change
-$0.07 (-0.02%)
Updated
Dec 26 closing price
Net Assets
1.48T
Interact to see
Advertisement

OSTFX vs VFFSX

Header iconOSTFX vs VFFSX Comparison
Open Charts OSTFX vs VFFSXBanner chart's image
Osterweis
Price$20.10
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets150M
Vanguard 500 Index Institutional Select
Price$339.11
Change-$0.07 (-0.02%)
VolumeN/A
Net Assets1.48T
OSTFX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
OSTFX vs. VFFSX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSTFX is a StrongBuy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.48T vs. OSTFX (150M). VFFSX pays higher dividends than OSTFX: VFFSX (1.13) vs OSTFX (0.15). OSTFX was incepted earlier than VFFSX: OSTFX (32 years) vs VFFSX (10 years). OSTFX (0.96) is less costly to investors than VFFSX (0.01). OSTFX is a more actively managed with annual turnover of: 42.00 vs. VFFSX (2.00). OSTFX has a lower initial minimum investment than VFFSX: OSTFX (5000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 14.85 vs. OSTFX (5.35). VFFSX return over 5 years is better than : 87.63 vs. OSTFX (1.34).
OSTFXVFFSXOSTFX / VFFSX
Total Expense Ratio0.960.019,600%
Annual Report Gross Expense Ratio0.960.019,600%
Fund Existence32 years10 years-
Gain YTD7.65917.91643%
Front LoadN/AN/A-
Min. Initial Investment500050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets150M1.48T0%
Annual Yield % from dividends0.151.1313%
Returns for 1 year5.3514.8536%
Returns for 3 years26.8680.7633%
Returns for 5 years1.3487.632%
Returns for 10 years-13.17N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHOE15.990.86
+5.68%
Phoenix Asia Holdings Limited
CAPR29.680.78
+2.70%
Capricor Therapeutics
HALO68.410.05
+0.07%
Halozyme Therapeutics
CHPGU10.21N/A
N/A
Championsgate Acquisition Corp
GROV1.17-0.03
-2.50%
Grove Collaborative Holdings